Get all premium features to the best stock analysis tool

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced the addition of Tyler Sloat to its board of directors. Sloat currently serves as the Chief Financial Officer and Chief Operating Officer of Freshworks Inc., where he oversees accounting, finance, IT, security, workplace, corporate strategy and revenue enablement. “Tyler brings decades of deep operating experience,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “His track record of scaling public companies wit.

Hinge Health Inc. (HNGE) reported earnings 30 days ago. What's next for the stock?

The mean of analysts' price targets for Hinge Health Inc. (HNGE) points to a 26.3% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

The cost of healthcare in the United States is on the rise in a big way. In its 2026 healthcare outlook, the Big Four accounting firm PricewaterhouseCoopers (PwC) made strong statements confirming this reality.

The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Hinge Health is using artificial intelligence to keep physical therapy costs down for employers. The company improved revenue by 51% in 2025.

Hinge Health combines robust 2025 growth (51% revenue, 31% FCF margin) with best-in-class digital MSK therapy, serving 24.6M covered lives. HNGE trades at 12–14x 2026 FCF, with management guiding 25% revenue growth but strong signals this is conservative. Defensibility against AI disruption is high due to healthcare barriers, proprietary data, hardware integration, and clinical outcomes, supporting a durable moat.